Charles River Laboratories and Pfizer have entered into a marketing and distribution agreement to provide certain Pfizer-developed genetically modified research models to the biomedical research community. Charles River will supply pre-competitive, transgenic research models developed by Pfizer covering a range of therapeutic areas, including neuroscience, diabetes and cardiovascular disease. “Charles River is extremely pleased to partner with Pfizer to further expand our growing portfolio o...